CDRH Ponders Role In Light Of Increased Patient Activism, Global IT
This article was originally published in The Gray Sheet
Executive Summary
FDA's role in explaining to the public the importance of evidence-based evaluation of new medical products will become increasingly important as consumer activism continues to grow, Center for Devices and Radiological Health Director David Feigal predicted.